MarketPeel
CHIEF FINANCIAL OFFICER
Mon, Aug 17, 2026
8d ago
sold $270.17k of ELVN
4,630 shares @ $58.35
Decreased holdings by -10.10%
3rd largest trade (out of 157)
Planned (10b5-1)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 71% above 200-day moving average
ELVNEnliven Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W-0.42%
1M+12.97%
3M+44.46%
6M
1Y

Recent insider activity at ELVN

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback